Combined esterified estrogens and methyltestosterone versus esterified estrogens alone in the treatment of loss of sexual interest in surgically menopausal women

@article{Warnock2005CombinedEE,
  title={Combined esterified estrogens and methyltestosterone versus esterified estrogens alone in the treatment of loss of sexual interest in surgically menopausal women},
  author={Julia K. Warnock and Stephen G Swanson and Raymond W Borel and Lisa M Zipfel and John J. Brennan},
  journal={Menopause},
  year={2005},
  volume={12},
  pages={374-384}
}
Objective:To compare the effect of esterified estrogens and methyltestosterone versus esterified estrogens alone on diminished sexual interest in surgically menopausal women. Design:This randomized, double-blind study compared the effect of combined esterified estrogens (1.25 mg) and methyltestosterone (2.5 mg) (EE/MT) versus esterified estrogens (1.25 mg) alone (EE) for 8 weeks. Several different sexual function questionnaires were used to measure response to therapy. Changes from baseline in… 
Testosterone patch for the treatment of hypoactive sexual desire disorder in naturally menopausal women: results from the INTIMATE NM1 Study
TLDR
Testosterone patch treatment increased the frequency of satisfying sexual activity and sexual desire, decreased personal distress, and was well tolerated in naturally menopausal women with hypoactive sexual desire disorder.
Effects of hormone treatment on sexual functioning in postmenopausal women
TLDR
If pharmacotherapy is indicated, tibolone should be considered as a first line treatment option for postmenopausal women with sexual dysfunction as its efficacy and medium to long term tolerability & safety is now sufficiently established.
Androgen and menopause
  • W. Somboonporn
  • Medicine, Biology
    Current opinion in obstetrics & gynecology
  • 2006
Purpose of review Androgen therapy is being increasingly used in the management of postmenopausal women. The most common indication is to improve sexual function. The aim of this review is to
Androgen treatment in women
TLDR
Current evidence indicates that androgens have important biological effects in women, acting directly via androgen receptors in tissues, such as bone, skin fibroblasts, hair follicles and sebaceous glands, and indirectly via the aromatization of testosterone to estrogen on various sites.
Effects of Korean red ginseng on sexual arousal in menopausal women: placebo-controlled, double-blind crossover clinical study.
TLDR
Oral administration of KRG extracts improved sexual arousal in menopausal women and red ginseng extracts might be used as an alternative medicine in menopause women to improve their sexual life.
Estrogen and androgen hormone therapy and well-being in surgically postmenopausal women.
TLDR
Estrogen with or without testosterone may improve general well-being in some groups of surgically menopausal women, but only at supraphysiological levels of total testosterone and physiological levels of free testosterone.
Sexual function and metabolic/hormonal changes in women using long-term hormonal and non-hormonal contraceptives: a pilot study
TLDR
The use of non-hormonal LARCS improved sexual function and had a negative influence on sexual function, probably by blocking ovarian function, and thus reducing the production of androgens and estrogens.
Androgen insufficiency in women.
  • G. Braunstein
  • Medicine, Biology
    Growth hormone & IGF research : official journal of the Growth Hormone Research Society and the International IGF Research Society
  • 2006
...
1
2
3
4
5
...

References

SHOWING 1-10 OF 23 REFERENCES
Estrogen and estrogen-androgen replacement in postmenopausal women dissatisfied with estrogen-only therapy. Sexual behavior and neuroendocrine responses.
TLDR
Sexual desire, satisfaction and frequency in postmenopausal women taking hormonal therapy were improved significantly by combined estrogen-androgen therapy but not by estrogen or estrogen-progestin therapy, leading to the conclusion that androgens play a pivotal role in sexual function but that estrogens are not a significant factor determining levels of sexual drive and enjoyment.
A two-year, double-blind comparison of estrogen-androgen and conjugated estrogens in surgically menopausal women. Effects on bone mineral density, symptoms and lipid profiles.
TLDR
As compared to estrogen alone, E + A significantly improved BMD and was well tolerated in surgically menopausal women.
Addition of testosterone to estrogen replacement therapy in oophorectomized women: effects on sexuality and well-being
TLDR
The addition of testosterone undecanoate improved specific aspects of sexual function more than treatment with estrogen alone, and improvements in well-being and self-esteem were similar for both treatments.
Androgen enhances sexual motivation in females: a prospective, crossover study of sex steroid administration in the surgical menopause.
TLDR
It was clear that exogenous androgen enhanced the intensity of sexual desire and arousal and the frequency of sexual fantasies in hysterectomized and oophorectomization women, but there was no evidence that testosterone affected physiologic response or interpersonal aspects of sexual behavior.
Sex hormone-binding globulin changes with androgen replacement.
TLDR
It is demonstrated that treatment of hypogonadal men with T and hCG in the doses used increased free T levels above the basal levels for normal men, however, the effects of the increase in free T, as determined by a change in SHBG, were different depending upon the type of treatment.
Female hypoactive sexual desire disorder due to androgen deficiency: clinical and psychometric issues.
TLDR
The Sexual Energy Scale was developed to provide an objective means of measuring the change in a patient's subjective experience of vitality/sexual energy with androgens replacement therapy and provides a clinical indication for androgen replacement dosage adjustment.
Testosterone concentrations in women aged 25-50 years: associations with lifestyle, body composition, and ovarian status.
TLDR
The greater circulating levels of testosterone in obese women and smokers suggest that testosterone concentrations should be considered in the natural history of disease conditions where obesity and smoking are risk factors, including cardiovascular disease.
...
1
2
3
...